MC
RBOT

Moors & Cabot’s Vicarious Surgical RBOT Stock Holding History

Moors & Cabot’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-353
Closed -$24.1K – 906
2023
Q1 		$24.1K Sell
353
-84
-19% -$6.53K ﹤0.01% 828
2022
Q4 		$26.5K Buy
437
+10
+2% +$930 ﹤0.01% 822
2022
Q3 		$43K Sell
427
-6
-1% -$699 ﹤0.01% 795
2022
Q2 		$38K Sell
433
-10
-2% -$1.22K ﹤0.01% 779
2022
Q1 		$67K Hold
443
– – ﹤0.01% 832
2021
Q4 		$141K Buy
443
+43
+11% +$15.2K 0.01% 798
2021
Q3 		$180K Buy
+400
New +$127K 0.01% 765

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Moors & Cabot's RBOT Position: Q2 2023 in Review

Moors & Cabot sold out of Vicarious Surgical (RBOT) in Q2 2023, closing a stake of 353 shares — an estimated $24.1K sold.

Moors & Cabot first reported a position in RBOT in Q3 2021 and held it in 7 quarters. The position peaked at $180K in Q3 2021. 74 funds tracked by Wall St. Rank hold RBOT as of Q2 2023.

  • Moors & Cabot reported no remaining Vicarious Surgical position as of Q2 2023 after selling out during the quarter.
  • Moors & Cabot sold 353 Vicarious Surgical shares in Q2 2023, an estimated $24.1K.
  • Moors & Cabot first reported a position in Vicarious Surgical in Q3 2021 and held it in 7 quarters.
  • Moors & Cabot's Vicarious Surgical position peaked at $180K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2023.

Based on Moors & Cabot's 13F filing for Q2 2023, filed 10 Aug 2023.